• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    WuXi PharmaTech (Cayman) Inc. (WX)

    -NYSE
    40.96 Up 0.26(0.64%) Mar 5, 4:02PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 578,082   499,912   407,177  
    Cost of Revenue366,518  316,674  250,733  
    Gross Profit 211,564   183,238   156,444  
    Operating Expenses
    Research Development10,950  8,136  5,409  
    Selling General and Administrative95,370  82,268  67,225  
    Non Recurring -  3,415   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 105,244   89,419   83,810  
    Income from Continuing Operations
    Total Other Income/Expenses Net34,740  16,276  14,565  
    Earnings Before Interest And Taxes139,984  105,695  98,375  
    Interest Expense1,953  1,718  790  
    Income Before Tax138,031  103,977  97,585  
    Income Tax Expense23,464  17,393  16,606  
    Minority Interest -   -   -  
    Net Income From Continuing Ops114,567  86,584  80,979  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 114,567   86,584   80,979  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 114,567   86,584   80,979  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.